chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 5-6 minutes after receiving the injection, I felt palpitations and my heart racing. I thought it was anxiety due to receiving the vaccine (though I had never had symptoms like that ever before), so I started deep breathing to try to calm down.  It continued to worsen but then stopped after approximately 2 - 3 minutes after deep breathing. I did not check my pulse during the episode but it felt like a regular rhythm, just elevated rate.  No medical attention or treatment was needed.  My heart rate was elevated for approximately 20-30 minutes afterwards (around 100bpm; my baseline is in the 70s).  During the episode, it felt much higher than 100bpm. I have had no further symptoms since then.
My symptoms started on the morning of November 22, 2022. I woke up with a fever, chills, body aches, a cough, and a sore throat. I took a COVID-9 test. The result was negative. My symptoms lasted for four months. I still had a residual cough. My cough started to improve after three and a half months. As of two weeks ago, I was able to resume exercise. Before I became ill, I was exercising approximately two hours a day. After four months, I received a diagnosis of Respiratory Syncytial Virus.
Chills lump/soreness in armpit of the arm for the vaccine extreme lower back pain....3 days
pt recv vax 12SEP95 & 13SEP95 presented to MD because inj site in lt arm had become reddened, swollen, hot & painful;prescribed meds;
Narrative:  Patient required 24/7 observation after the vaccine due to severe lethargy and confusion
Blurry vision/ unfocused from time to time to current date. Daily headaches to date. Muscular pain/tenderness (last week of October) in legs, upper and lower, upper arms, neck, shoulders, feet. Getting progressively worse. Fatigue.
I had a slight sore throat on 01/31/2023. Then on 02/01/2023 my sore throat got stronger, and my fever was 99.4. I tested for COVID-19 and it came back positive. On 02/02/2023 I then reached out to my provider and prescribed PAXLOVID. During taking PAXLOVID my kidney volume went done and could not go pee. My fever went up to 101 and congestion. On 02/03/2023 my cough got more, coughing up stuff that was unclear. On 02/04/2023 my fever was gone but my sore throat was really strong and also experienced nausea. On 02/05/2023 my sore throat was gone but I was really fatigued, nauseous and congested. My cough then became a dry cough, and I was really weak. My symptoms lasted about a week and a half.
Right eye significant swelling and itching.  After the first shot, swelling occurred within 4 hours of injection and took about 2 weeks to subside.  After the second shot, swelling did not occur until 5 days after the injection, but the swelling is more dramatic.
Woke up sweating over whole body; dizziness, eyes started rolling in the back of head.
It was reported that a female pt received a Rabies Imovax vaccination on 4/24/01. Reportedly, that same day, the pt developed general malaise and purple discoloration of the lower back part of her arm where the vaccine was administered. The pt was evaluated by a physician and was told the reactions were not vaccine related.
Patient is not experiencing any side effects.  She was given the high dose when she is 63 and should have received the regular dose.
She developed a right cranial nerve 7 palsy 18 hours after vaccination and then developed vertigo, right-sided hearing loss and tinnitus.  She completed a 7 day course of prednisone and Valtrex for Bell's palsy.
On 05/10/2021 developed dull headache on and off, no fever or other symptoms at the time or prior.  Saturday, 05/15/2021 developed dime size bright redness w/itchiness at injection site LD. On Sunday, 05/11/2021 area increased to the size of a quarter, increased redness, swelling and itching. Monday, 05/12/2021 area increased to the size of a baseball,  same color and itchiness began taking  OTC Benadryl "smallest dose" once a day which helped decrease itchiness.   Tuesday, 05/13/21 entire area above elbow was now swollen but itchiness gone as Benadryl was still being taken Q day.  Wednesday, 05/14/2021 same size swelling but lighter pink and itchiness remains under control with Benadryl and color did get to a lighter pink.  Visited Medical Center and was instructed that they could not help until the issue was reported to the center where you got the vaccine.  Case called vaccination center and left VM. Returned VM today and this report made.  Currently, L arm is pink and still the same size which remains the entire upper arm from level of vaccine site (deltoid) to just above elbow.  Minimal pain upon  advanced movement "but I am very nervous about it."
Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider/healthcare providers recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 03-JUN-2010, a healthcare provider (not further specified) administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). In 2015, the patient was treated by Healthcare provider(s) (unspecified health care professional) for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Causality assessment considered events to be related to the use of ZOSTAVAX. Additional information has been requested.
Headache, Sedation, Myalgia, chills, metallic taste in mouth Narrative:
pt recv vax 15JAN96 & 18JAN96 pt exp a rash that was itchy & blotchy;pt reported that rash lasted for a couple days, but returned p/went running;
Patient reports feeling dizzy with nausea after vaccine. No shortness of breath, no chest pain, no headache, no rash. Patient reported she has not eaten since breakfast. Vital signs were stable: HR 92 regular BP 110/72 RR 16. Patient was given water and observed for for 30 minutes. Patient stated feeling better and sent home with mother in law. Patient instructed to call primary care if symptoms persist and 911 if  symptoms worsen.
Immunization site (Left Arm) was Red, swollen, and full of heat.  Painful to touch.
FALL; BRUISED SHOULDER FROM FALL; BRUISED HIP FROM FALL; BLACK EYE FROM FALL; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced fall, bruised shoulder from fall, bruised hip from fall, and black eye from fall. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fall, bruised shoulder from fall, bruised hip from fall and black eye from fall was not reported. This report was non-serious.
2/2/2021 Date of Vaccination  Slight soreness in arm by evening 2/3/2021 No new symptoms 2/4/2021 No new symptoms 2/5/2021 3 AM started with Severe heartburn, 2 episodes of loose stools early AM, took heartburn medicine, sat up in chair all day, sleeping on and off.  11 AM chills, could not get warm  2 PM fever 100.8, significant body aches Took Tylenol 1000mg  4 PM Woke up covered in sweat, disoriented, extremely weak, needed help to get his shirt off and to get out of his chair and walk to Bathroom, urinated on himself because he couldn't get to bathroom in time.  Fever throughout the evening and night. 2/6/2021 11 AM temp 101 Feeling slightly better than yesterday. Diarrhea 9 episodes this day. Took Pepto Bismol.  Able to eat chicken noodle soup today. Slept most of the day. 2/7/2021 Fever gone, feeling some better overall but not back to normal yet. rested all day. Discovered itchy rash on his abdomen. 2/8/2021 Feeling good except rash on abdomen and now on arms.  Rash lasted 3 more days. No further symptoms after that.
Patient received COVID vaccine #1 on 4/9/2021. She received Moderna.  We administered COVID vaccine #2 on 8/16/2021- Pfizer.  Patient did not have any adverse reactions to the vaccine.
Patient stated he started with arm soreness and fever with body aches. Patient noted arm getting red with swelling and hot to touch. Pt. took ADVIL only. Pt. stated redness and swelling was getting better since yesterday when he reported to clinic.
ACUTE RESPIRATORY FAILURE CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
On 1/21/2021 approximately 19 hours after received injection began having chills, a few hours later developed shaking chills and body aches, especially in back, felt feverish but had no thermometer at home to check temp, Body aches, chills and fatigue continued into early afternoon on 1/22/2021 but resolved by later in afternoon.
A report was received from a health care professional on 12/11/03 concerning a 2 year old female vaccinee who inadvertently received Fluvirin on an unknown date. On an unknown date the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
I was only 8 weeks pregnant (4/7/21) when I received the J&J with an ultrasound at 8 weeks it was a missed miscarriage (No heartbeat or fetus). I ended of miscarrying around a few weeks later.  I wasn't feeling well the week of April 18th. Some symptoms included out of breath, a bit nauseous and finally the day I went to the ER (April 26th or 27th) my leg was sore in my calf-muscle. I went on the CDC'c website and found I had symptoms of a blood clot.  I was admitted into the hospital with blood clots in my leg that travelled to my chest.
first shot- starting two days after and lasting 2 weeks- when I turn my head it feels like it takes a few seconds for my eyes to catch up.   second shot-starting two days after and now I'm on my fourth week post vaccination- have the same feeling that when I turn my head it feels like it takes a few seconds for my eyes to catch up.  I'm an RN and felt that the manufacturer needed to know this is happening. I'm able to function, but the feeling is still there.
About 24 hrs after influenza vaccine given, pt reported to have cluster of suspected seizures (shaking right leg then other extremities, stiffening turning head to right, unresponsive for 10-15 minutes later sleepy. While at day care. Sleepy.  Normal exam when seen that afternoon.
Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022; patients who received expired doses of the Moderna COVID vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patients who received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patients who received expired doses of the Moderna COVID vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patients who received expired doses of the Moderna COVID vaccine) and PRODUCT STORAGE ERROR (Vaccines placed in refrigerator on 13-Jan-2022 and dose admistered to patient on 17-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that the vaccines were placed in refrigerator on 13-Jan-2022. Expiration date placed on vial was12-Feb-2022.  No concomitant medication was reported by the reporter. No treatment medication was reported by the reporter.
became dizzy, nauseated, pale, weak and almost fainted 5 minutes after the injection.
Rash on left foot occurred several weeks after vaccination. approx 2 weeks later more rashes occured on my right foot. All primarily around the knuckle area of toes. They do not itch or burn but are red/pink in color and unsightly. I did have Covid confirmed 1/2/21 (I believe that was the date)
Diarrhea; Weakness; cough; headache; fatigue; chills; Arm felt heavy; A spontaneous report was received from a non-health professional concerning a 62-year-old ,patient who received Moderna's COVID-19 vaccine and developed chills at night, heaviness in her arm, cough, fatigue, diarrhea and weakness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 27 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.     On 27 Dec 2020, the same day as the vaccination, the patient's arm felt heavy. On 28 Dec 2020, she developed chills at night. Then 3 days after the vaccination, on 30 Dec 2020, the patient experienced fatigue, headache, cough, diarrhea and weakness.   Treatment for the events included, acetaminophen for the headache. Mucinex and a cough syrup for the cough.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The outcome for the events were ongoing.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Red, warm rash on right arm roughly 2 inches below injection site. Initially occurred roughly 72 hours following vaccination. Over the following 24 hours it grew to roughly baseball size, and has since remained about the same size. It is reported to be tender to the touch with a burning sensation from clothing.
On 1/4/2007, pt was given first dose of Gardasil vaccine. Also, on that day, changed OCP from Lo-ovral to Ovcon-35 because of spotting. Presnted 1/22/07 with pruitic rash consisting of tine erythematous papules on arms/legs/trunk
Swelling, red raised injection site reaction measuring 4 inches long and 3 and 1/2 inches across, sharp pain localized behind the shoulder blade which was aggravated by turning the head.
Reports pain and itching in left arm, in addition to a headache, on 02/09/2021. Arm became reddened, hard, and warm to touch on 02/10/2021. Also reports chills and fever 02/10/2021. Presents to the health department today, 02/12/2021, with symptoms still persisting. Reports taking benadryl this morning with some resolution in itching but not completely.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Additional Details: 3 minutes post vaccination patient was pale, experiencing diaphoresis, felt funny. Immediately he drank apple juice and right after still felt like he was going to faint. As he was sitting upright in chair talking his eyes rolled back in his head and he became unresponsive. I had him lie down and propped up his feet. Called 911 and took his blood pressure. He regained consciousness but was still not coherent. He attempted to sit in chair again and immediately felt like he was going to pass out
This is a spontaneous report from a contactable nurse via a Pfizer sales representative. A 17-year-old female patient received TRUMENBA (batch number unknown), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced a large red ring around the injection site on an unspecified date after the use of the product. The outcome of the event was unknown. Information on the batch number has been requested.
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 12-JUN-2012, patient received improperly stored VARIVAX dose 2, from lot # 671861/1907AA expiry date: 05-DEC-2013. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
break out on my forehead. Small red bumps/pimples; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Apr2021 09:30 (Lot number: ER8732) at the age of 30 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: ACNE (non-serious) with onset 03Apr2021 12:00, outcome "recovering", described as "break out on my forehead. Small red bumps/pimples". Therapeutic measures were not taken as a result of acne.  Additional Information: The patient reported that she administered other pfizer vaccine on 02Apr2021 with Lot# EW0158 administered on left arm and she did not specify the vaccine name and other medications in two weeks were none. It was reported that the patient never had covid prior vaccination and not tested for covid post vaccination. Known allergies were no/unknown.  No follow-up attempts are possible. No further information is expected.
Woke up at 03:00am after getting the vaccine the prior evening at 05:00pm. I was running a fever of 102.9, had body aches, was dizzy, and felt extremely nauseated. By 06:00am I had a terrible headache also. This continued the entire day until approximately 5:30 the following morning. I received the vaccine on 10/1/21 and on 10/6/21 I went to the Emergency room around 6:00pm due to intense chest pain that was radiating into my left shoulder and back. I've never had any cardiac issues. I've never had anything like that before. It was a sharp shooting pain. It lasted pretty consistently for approximately 7 hours that evening until it finally let up and just felt more of a dull pain. All of my lab values came back within normal ranges and my EKG was normal.
Covid-19,  mRNA,  LNP-S,  bivalent,  PF  mcg/0.5 mL Dose (Moderna)  Raised 2 1/2  inch round, raised red rash on injection site.  Rash felt hot and the complete circle was all red.  It's slowly going away now.
patient report feeling something in her throat "lump on right side, tight."  25mg of Benadryl given IM
ADMITTED TO HOSPITAL C/C WEAKNESS  WITH WORSENING DYSPNEA FOR 3-4 DAYS INCREASED OXYGEN REQUIREMENT
Pfizer-BioNTech COVID- 19 Vaccine EUA Moderna COVID- 19 Vaccine EUA  Patient received COVID-19 Vaccine dose #1 as Moderna from a different provider,  and dose #2 as Pfizer on February 25, 2021.  Patient did not disclose dose #1 was administered on February 3, 2021 until after the dose on February 25, 2021 was administered.
Pt. was given a DTaP injection to (R) deltoid area on 3/15/11. On 3/16/11 pt's mother called & stated she needed to bring her dtr. in. When she arrived, child was in no noticeable distress, but did have 7.6 x 5.6 cm red, swollen area to upper (R) arm. C/o pain & itching. Dr. examined area & instructed her mother to continue BENADRYL.
Headache, Arthralgia, Fatigue, chills nausea Narrative:
Rash-pimple like to affected arm, in clusters started 2 days after injection. Spread to R chest and R back on affected side. Axillary lymph node swelling started approx 1 week after administration. Given antibiotics and prednisone to clear.
This spontaneous report as received from a nurse refers to a 57 year old patient. Medical history and concurrent conditions were not reported. On 23-JAN-2014, the patient was vaccinated with PNEUMOVAX 23 lot #J005067; expiration date: 17-JAN-2015 (dose, strength and route were not reported). Secondary and concomitant therapies were not reported. Nurse called and stated that improperly stored PNEUMOVAX 23 was administered to patient. No adverse effects reported. On 13-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 50 degrees F. On 18-JAN-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (2 pm - 4 pm) the temperature recorded was 49.1 degrees F. On 10-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (12 pm - 6 pm) the temperature recorded was 51.8 degrees F. On 16-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 5 hours (12 pm - 5 pm) the temperature recorded was 51.8 degrees F. On 22-FEB-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 4 hours (2 pm - 6 pm) the temperature recorded was 52.7 degrees F. On 09-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 2 hours (12 pm - 10 pm) the temperature recorded was 55.4 degrees F. On 15-MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 6 hours (8 am - 2 pm) the temperature recorded was 50 degrees F. On 16 MAR-2014, PNEUMOVAX 23 was stored outside of recommended temperatures for 20 hours (2 am - 10 pm) the temperature recorded was 64.4 degrees F. On 17-MAR-2014, PNEUMOVAX 23 the temperature reading on the morning was 64.8 degrees F. The total of hours stored outside of recommended temperatures was 55 hours. This is one of several reports from the same reporter. Additional information has been requested.
SYNCOPAL EPISODE BRIEF, NORMAL BLOOD PRESSURE, AND HEART RATE POST EPISODE; NO NEUROLOGICAL CHANGES; NO SEQUELAE; NO INTERVENTION NEEDED, OBSERVED IN CLINIC 30 MINUTES POST EPISODE.